| Dr Douglas Eugene Vanrees, DO | |
|
102 N Keel Ridge Rd, Senior Healthcare Associates -john Balko And Associates, Hermitage, PA 16148-3440 | |
| (800) 471-8592 | |
| (866) 742-6901 |
| Full Name | Dr Douglas Eugene Vanrees |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 102 N Keel Ridge Rd, Hermitage, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093799090 | NPI | - | NPPES |
| 0457590 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 34 002800V (Ohio) | Secondary |
| 208D00000X | General Practice | 34.002800 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Eugene Vanrees, DO 4114 S Raccoon Rd, Canfield, OH 44406-9373 Ph: (330) 793-8404 | Dr Douglas Eugene Vanrees, DO 102 N Keel Ridge Rd, Senior Healthcare Associates -john Balko And Associates, Hermitage, PA 16148-3440 Ph: (800) 471-8592 |
News Archive
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
Heart attack patients who experience cardiogenic shock have a higher risk of death or rehospitalization than non-shock patients in the first 60 days post-discharge, but by the end of the first year, the gap between the two groups narrows, according to a study published today in the Journal of the American College of Cardiology.
Research presented at the ASM Microbe research meeting provides compelling evidence that children acquire Streptococcus mutans, the bacterium most frequently associated with dental caries, from intra- and extra-familial sources besides their mother.
Pacira Pharmaceuticals, Inc., an acute care specialty pharmaceutical company, announced today that enrollment has been completed in two pivotal Phase III SIMPLE trials to evaluate the safety and efficacy of a single intraoperative administration of EXPAREL(TM) (DepoBupivacaine) for prolonged postoperative analgesia.
New research is helping to unravel the events that underlie the "spread" of Alzheimer's disease (AD) throughout the brain. The research, published by Cell Press in the November 4th issue of the journal Neuron, follows disease progression from a vulnerable brain region that is affected early in the disease to interconnected brain regions that are affected in later stages. The findings may contribute to design of therapeutic interventions as targeting the brain region where AD originates would be simpler than targeting multiple brain areas.
› Verified 8 days ago
Mr. Sri Chandra Swami, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 701 North Hermitage Rd, Hermitage, PA 16148 Phone: 724-981-3322 Fax: 724-981-6760 |